Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | SPHK2 | Q9NRA0 | 1/20 | 0.39 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.39 |
| ▸ | GBA2 | Q9HCG7 | 14/20 | 0.38 |
| ▸ | GBA1 | P04062 | 9/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | CES2 | O00748 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5935738 | 0.73 | ALDH1A1 (0.49) | MEN1THRBHTTKMT2AMAPT | |
| SCHEMBL7569036 | 0.72 | GBA1 (0.37) | MEN1THRBHTTKMT2AMAPT | |
| SCHEMBL5177072 | 0.71 | MEN1 (0.58) | MEN1THRBHTTKMT2AMAPT | |
| Cyclohexanol SCHEMBL21175580 | 0.71 | MEN1 (0.52) | MEN1THRBHTTKMT2AMAPT | |
| Cyclopentane SCHEMBL29210118 | 0.70 | THRB (0.61) | MEN1THRBHTTKMT2AMAPT | |
| Methyl Alcohol SCHEMBL5708979 | 0.70 | HTT (0.67) | MEN1THRBHTTKMT2AMAPT | |
| SCHEMBL8773 | 0.69 | THRB (0.65) | MEN1THRBHTTKMT2AMAPT | |
| Hexane SCHEMBL3260754 | 0.69 | THRB (0.65) | MEN1THRBHTTKMT2AMAPT | |
| SCHEMBL9011679 | 0.69 | THRB (0.65) | MEN1THRBHTTKMT2AMAPT | |
| SCHEMBL9011627 | 0.69 | THRB (0.65) | MEN1THRBHTTKMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1115702-A4 | SUBSTITUTED NITROGEN AND SULFUR ALICYCLIC COMPOUNDS, INCLUDING METHODS FOR SYNTHESIS THEREOF | MILLENNIUM PHARM INC (US) | 2002-04-17 | — | — | EP | disclosed |
| EP-1115702-A1 | SUBSTITUTED NITROGEN AND SULFUR ALICYCLIC COMPOUNDS, INCLUDING METHODS FOR SYNTHESIS THEREOF | Millennium Pharmaceuticals, Inc. (US) | 2001-07-18 | — | — | EP | disclosed |
| WO-2000001670-A1 | SUBSTITUTED NITROGEN AND SULFUR ALICYCLIC COMPOUNDS, INCLUDING METHODS FOR SYNTHESIS THEREOF | LEUKOSITE, INC. (US) | 2000-01-13 | — | — | WO | disclosed |